STARTUP PROFILE

NeuroBionics

COUNTRY
USA
FOUNDED
2023
CATEGORY
Tools and Infrastructure
Developing minimally invasive implantable bioelectronic fiber systems for targeted neuromodulation therapies and integrated neural interfacing in clinical and research contexts.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Endovascular
FORM FACTOR
Implant
INTERFACE DEPTH
Minimally invasive
INDICATION
Multi-indication
TARGET USER
Mixed
REGULATORY STAGE
Preclinical
NeuroBionics is positioned at the materials-and-interface frontier, developing implantable bioelectronic fibers for targeted neuromodulation and sensing. This places it as enabling infrastructure for future implants rather than a fully formed therapeutic company today.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
9
BCI Shows its Value
1 September – 15 September 2026

NeuroBionics received a Phase II NSF SBIR grant to advance its IO Fiber platform, a multifunctional neural probe for researchers. The flexible fiber combines electrical and optical recording and stimulation with localized fluid delivery, replacing several separate probes in complex experiments. The funding supports manufacturing scale-up and commercialization. The Cambridge company is also developing the underlying bioelectronic-fiber technology toward less invasive therapies such as deep brain stimulation.

Articles featuring
NeuroBionics